癌の生存者に対するケアモデルの改善
Michael Jefford1, Doris Howell2, Qiuping Li3
1Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
Lancet (London, England)
|April 17, 2022
まとめ
癌の生存者のケアモデルが進化しています プライマリケアや看護師主導のケアを含む代替アプローチは,生活の質を改善し,生存者のニーズを効果的に管理する見込みを示しています.
科学分野:
- 腫瘍学
- 医療管理
- 患者 介護
背景:
- 癌の生存者の増加は 現在の医療システムに 課題を投げかけています
- 既存のケアモデルは 癌の生存者の 多様で複雑なニーズを満たすのに 往々にして失敗しています
- 持続可能で効果的ながん生存者ケアモデルが不可欠です
研究 の 目的:
- 癌の生存者の治療の代替モデルを見直し評価する.
- 生き残った人のための適切なケアモデルの選択に影響を与える要因を特定する.
- 将来のがん生存者ケア戦略の改善を提案する.
主な方法:
- 代替医療モデルを調査する多数の試験のレビュー
- 患者レベルの要因,地元のサービス,医療政策の分析
- パンデミックに起因する医療提供の変化を考慮する.
主要な成果:
- 代替ケアモデル (プライマリーケア主導,共有ケア,看護師主導) は,専門医主導のケアと同じくらい効果的です.
- これらのモデルは幅広い癌の生存者に適用できます
- 患者の要因や 地域の資源や政策が モデル選択に影響します
結論:
- より広範な実施には 非腫瘍学者の提供者への支援と チームの承認が必要です
- 将来のモデルは,再発の検出のみよりも,生活の質,機能的結果,患者体験を優先すべきである.
- 研究は様々な医療環境と癌の種類に拡大すべきです.
関連する概念動画
01:21Cancer Survival Analysis
472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:30Cancer Vaccines
533
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
533
01:27Tumor Immunotherapy
689
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
689
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K